• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Aspirin-like pain reliever diflunisal blocks hearing protein

Bioengineer.org by Bioengineer.org
January 25, 2018
in Headlines, Health, Science News
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Jeff Fitlow/Rice University

A Rice University study has found that the aspirin-like drug diflunisal blocks the action of prestin, a key protein that is required for hearing.

The research, which is available online in the open-access journal PLOS ONE, stemmed from a 2015 Rice study that screened more than a half-dozen nonsteroidal anti-inflammatory drugs, or NSAIDs, for possible interactions with the protein prestin. Prestin is a highly specialized protein that drives the action of outer hair cells in the cochlea, an inner-ear organ that allows people and animals to hear.

"Taking too much aspirin can cause temporary deafness, and researchers discovered more than a decade ago that this happens because salicylate, one of the primary metabolites of aspirin, interferes with prestin," said study lead author Guillaume Duret, a research scientist in Rice's Department of Electrical and Computer Engineering. "Given the number of commonly used NSAIDs that operate in a similar way to aspirin, it seemed like a good idea to find out whether they also might inhibit prestin."

Duret said diflunisal was the only drug in the test that blocked the action of prestin. He said the findings suggest that the inhibition occurs by competing with chloride ions in prestin, a mechanism that is similar to what has been proposed for salicylate. The study also found that the dosage needed to induce a reaction was less than the aspirin dose required to induce a similar reaction.

Diflunisal is primarily prescribed as a mild pain killer and an anti-inflammatory for arthritis. But Duret said the findings come at an important time because the medical community is considering repurposing diflunisal as a possible treatment for both cancer and amyloid polyneuropathy.

"So far, it's been used in a pill form that is ingested, and the known side effects are for relatively small doses, like as if you were taking aspirin," Duret said. "For greater doses that are perhaps injected, the side effects may not yet be known."

He conducted the study's experiments in 2015 with two of the world's leading experts on prestin and outer hair cells, Rice bioengineer Rob Raphael and Baylor College of Medicine molecular biologist Fred Pereira.

The new findings weren't easy to obtain. They involved dozens of painstaking experiments in which Duret isolated and measured the activity of live outer hair cells from the cochlea of mice. To get his measurements, Duret had to find the cells under a microscope, grab hold of them with a glass pipette and apply and measure current through a process known as whole-cell patch clamping. The tests had to be performed both with and without the presence of diflunisal and before the short-lived cells died.

Raphael, who has studied prestin for more than 15 years and who made some of the first discoveries about salicylate's interference with prestin, said live-animal testing is needed to determine whether diflunisal causes deafness and at what dose.

"In addition to the potential clinical significance, Guillame's carefully done research has helped us refine our understanding of how molecules interact with prestin and how prestin itself operates," Raphael said.

He said the study also revealed a direct effect of diflunisal on the hair cell membrane, a result that may have implications for other physiological systems.

"This study comes at a time where there is considerable excitement about new fields like systems and synthetic biology," said Raphael, who's lab is developing systems-level models of ion transport in the cochlea.

"This is a reminder that we still don't have a basic understanding of how commonly used drugs affect important proteins in our cell membranes," he said. "Sometimes, even the discoveries in your own lab humble you to the magnitude of what we still do not know about biological systems."

The research was supported by the National Institutes of Health.

SUMMARY:

A Rice University study has found that the aspirin-like drug diflunisal blocks the action of prestin, a key protein that is required for hearing.

Rice University
Office of Public Affairs / News & Media Relations

David Ruth
713-348-6327
[email protected]

Jade Boyd
713-348-6778
[email protected]

The research was supported by the National Institutes of Health.

High-resolution IMAGES are available for download at:

0824_DIFLUNISAL-duo-sml http://news.rice.edu/files/2017/08/0824_DIFLUNISAL-duo-lg-2au5huv.jpg CAPTION: Rob Raphael (left) and Guillaume Duret (Photo by Jeff Fitlow/Rice University)

The DOI of the PLOS ONE paper is: 10.1371/journal.pone.0183046

A copy of the paper is available at: https://doi.org/10.1371/journal.pone.0183046

Related stories from Rice:

Rice, BCM explore nanoscale biophysics of key hearing protein — April 23, 2009 http://news.rice.edu/2009/04/23/rice-bcm-explore-nanoscale-biophysics-of-key-hearing-protein/

New findings help explain hearing loss — Oct. 31, 2007 http://news.rice.edu/2007/10/31/new-findings-help-expain-hearing-loss/

Rice study finds aspirin-induced ulcers, hearing loss caused by same mechanism — Oct. 6, 2005 http://news.rice.edu/2005/10/06/rice-study-finds-aspirin-induced-ulcers-hearing-loss-caused-by-same-mechanism/

This release can be found online at news.rice.edu.

Follow Rice News and Media Relations via Twitter @RiceUNews

Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation's top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,879 undergraduates and 2,861 graduate students, Rice's undergraduate student-to-faculty ratio is 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for quality of life and for lots of race/class interaction and No. 2 for happiest students by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger's Personal Finance. To read "What they're saying about Rice," go to http://tinyurl.com/RiceUniversityoverview.

Media Contact

David Ruth
[email protected]
713-348-6327
@RiceUNews

http://news.rice.edu

Related Journal Article

http://dx.doi.org/10.1371/journal.pone.0183046

Share13Tweet7Share2ShareShareShare1

Related Posts

blank

Dual-Mode X-ray and NIR Imaging with Bifunctional Scintillators

September 11, 2025
Turning Noise into Power: Unveiling the Symmetric Ratchet Motor Breakthrough

Turning Noise into Power: Unveiling the Symmetric Ratchet Motor Breakthrough

September 11, 2025

Redox Minerals and Organics in Jezero Crater

September 11, 2025

How Virtuousness Boosts Nurses’ Commitment Through Just Culture

September 11, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    63 shares
    Share 25 Tweet 16
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Dual-Mode X-ray and NIR Imaging with Bifunctional Scintillators

Turning Noise into Power: Unveiling the Symmetric Ratchet Motor Breakthrough

Redox Minerals and Organics in Jezero Crater

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.